-
Publication / Ieva Andersone, Private: Gunvaldis Leitens
Commercial drug names will no longer appear in hospital records New amendments to Cabinet of Ministers Regulations No. 265 “Procedures for Keeping Medical Documents” have recently been adopted by the Cabinet of Ministers. The plan is that from 1 January 2020, when providing information on medicines to be used for further treatment, only the active […]
-
Government initiates bill to cancel pharmacy reform The parliamentary Social Affairs Committee has initiated a bill to cancel pharmacy reform. Although supported by the coalition government, the bill did not pass the first reading in the parliament. As a result, at the present moment uncertainty around pharmacy reform continues. The plan to cancel pharmacy reform […]
-
Publication / Marina Golovnitskaya, Yauheni Budchanka
Updating list of licensed medical activities Draft amendments to the list of licensed medical activities have been published for public discussion. Discussion was closed on 12 December 2019. As of now, it is unclear whether the amendments will be adopted and, if so, when it will happen. The purpose of the draft amendments is to clarify and […]
-
On 25 November 2019, the Latvian Competition Council (Council) published a report on “Medicines: Price formation and possible restrictions on competition affecting their financial availability”. The aim of the study was to consider the factors affecting prices and financial availability of medicines in Latvia. The study compared the regulatory frameworks of Latvia, Lithuania and Estonia […]
-
Publication / Marina Golovnitskaya, Kirill Laptev, Yauheni Budchanka, Pavel Lashuk,
1. Introduction The introduction should provide an overview of the relationship between pharma regulation and general privacy and data protection law. 1.1. Legislation Key acts, regulations, directives governing the health and pharma sector, and which are relevant to privacy and data protection The key legal act governing the health and pharma sector is the Law […]
